logo
Book a meeting
SciNeuro Pharmaceuticals

Sci Neuro Pharmaceuticals

Biotechnology, 8 Clarke Dr, Rockville, Maryland, 08512, United States, 11-50 Employees

scineuro.com

  • LinkedIn

Who is SCINEURO PHARMACEUTICALS

SciNeuro Pharmaceuticals is a clinical-stage biotechnology company focused on developing groundbreaking therapies for neurodegenerative diseases. Since its founding in 2020, SciNeuro has ...

Read More

lock icon Get Full Access
map
  • 8 Clarke Dr, Rockville, Maryland, 08512, United States Headquarters: 8 Clarke Dr, Rockville, Maryland, 08512, United States
  • 2020 Date Founded: 2020
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 456110 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from SCINEURO PHARMACEUTICALS

SciNeuro Pharmaceuticals Org Chart and Mapping

Employees
Zusheng Li

Zusheng Li

Associate Director, Antibody Discovery & Development

Yuka Martens

Yuka Martens

Director, Head of Biology

Diana Eng

Diana Eng

Senior Associate Scientist

Marybeth Curtis

Marybeth Curtis

Senior Scientist

See Full Org Chart arrow
email-formate-icon
View Email Formats for SciNeuro Pharmaceuticals
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding SciNeuro Pharmaceuticals

Answer: SciNeuro Pharmaceuticals's headquarters are located at 8 Clarke Dr, Rockville, Maryland, 08512, United States

Answer: SciNeuro Pharmaceuticals's official website is https://scineuro.com

Answer: SciNeuro Pharmaceuticals's revenue is Under $1 Million

Answer: SciNeuro Pharmaceuticals's SIC: 2834

Answer: SciNeuro Pharmaceuticals's NAICS: 456110

Answer: SciNeuro Pharmaceuticals has 11-50 employees

Answer: SciNeuro Pharmaceuticals is in Biotechnology

Answer: SciNeuro Pharmaceuticals contact info: Phone number: Website: https://scineuro.com

Answer: SciNeuro Pharmaceuticals is a clinical-stage biotechnology company focused on developing groundbreaking therapies for neurodegenerative diseases. Since its founding in 2020, SciNeuro has built a portfolio of pipeline programs staged from discovery to clinical development by addressing three key disease-driving mechanisms of neurodegeneration neurovascular inflammation, proteinopathy, and immune response. The company aims to develop disease-modifying treatment options for Alzheimers disease, Parkinsons disease, and other devastating CNS diseases.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access